Date: 2015-01-09
Type of information: Distribution agreement
Compound: automated platforms including the WASP® Walk-Away Specimen Processor and the WASPLab™ solutions
Company: bioMerieux (France) Copan (Italy)
Therapeutic area: Diagnostic
Type agreement: collaboration distribution
Action mechanism: The WASP® Walk-Away Specimen Processor is an instrument for liquid sample processing for microbiology. The WASP® provides a comprehensive system which encompasses all aspects of automated specimen processing: planting and streaking, Gram slide preparation, enrichment broth inoculation and Kirby-Bauer set-up and disk application. Designed to transform the work of laboratory managers and technologists, the WASPLab™ system moves current laboratories to the digital microbiology era through high resolution culture plate images, improving speed, interpretation, reliability and accessibility of results.
Disease:
Details: * On January 9, 2015, bioMérieux, a world leader in the field of in vitro diagnostics, and Copan, a leading manufacturer of innovative pre-analytic solutions, have signed a strategic partnership in clinical microbiology laboratory automation. Under the terms of the agreement, Copan has granted distribution rights for its automated platforms (including the WASP® Walk-Away Specimen Processor and the WASPLab™ solutions which automate microbiology laboratory tasks and provide digital imaging and analysis) to bioMérieux. This agreement allows bioMérieux to speed up deployment of its “FMLA® - Lab Efficiency*” vision for the automation and enhanced operational efficiency of clinical microbiology labs. In this field, the two companies also plan to collaborate in particular for the development of innovative clinical microbiology diagnostic solutions. This agreement combines Copan’s know-how in pre-analytics with bioMérieux expertise in microbiological diagnostics. Since January 1st 2015, bioMérieux has been Copan’s exclusive distributor in France, and a co-exclusive distributor in Germany and the United Kingdom to distribute Copan’s WASP® and WASPLabTM systems. Then bioMérieux’s commercialization rights will gradually be expanded, on the basis of co-exclusive distribution, to a number of key countries. WASP® and WASPLabTM are innovative, flexible and robust. They meet the most demanding needs of microbiology laboratories and will enrich bioMérieux’s range of automated solutions, including BacT/ALERT® and VIRTUO™,blood culture systems, as well as VITEK® 2 and VITEK® MS for bacterial identification and automated antibiotic susceptibility testing. This agreement is part of bioMérieux’s “FMLA®” vision, renamed “Lab Efficiency.” In addition to automating certain tasks, laboratories would like to significantly enhance their operational efficiency, make up for the growing shortage of specialized staff, and obtain the accreditation they need to operate. This can be accomplished by streamlining workflows while delivering faster and more standardized results and improving traceability of analyses. The “bioMérieux - Copan” offering combines fully automated, modular and flexible diagnostic solutions of Copan and bioMérieux. Its roll-out adds value to laboratory customers and is based on an audit of workflows using the LeanSigma® method – the most effective method to optimize organizational performance to date – and on Myla® innovative middleware for the connection between instruments, for the management of microbiology laboratory workflows and for the centralization of the necessary information to interpret results. Sharing a common vision of open, modular automation, teams at bioMérieux and COPAN plan to work together closely. Driven by the momentum of innovative projects under development at both companies (workflow optimization, imaging and software algorithms), their collaboration should give rise to the joint development of new, interconnected diagnostic solutions in microbiology.
Financial terms:
Latest news:
